Coumarin metabolism, toxicity and carcinogenicity: Relevance for human risk assessment

被引:414
作者
Lake, BG [1 ]
机构
[1] BIBRA Int, Carshalton SM5 4DS, Surrey, England
关键词
coumarin; liver tumours; lung rumours; metabolism; risk assessment; species differences;
D O I
10.1016/S0278-6915(99)00010-1
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The metabolism toxicity and results of tests for carcinogenicity have been reviewed with respect to the safety for humans of coumarin present in foodstuffs and from fragrance use in cosmetic products Coumarin is a natural product which exhibits marked species differences in both metabolism and toxicity. The majority of tests for mutagenic and genotoxic potential suggest that coumarin is not a genotoxic agent. The target organs for toxicity and carcinogenicity in the rat and mouse are primarily the liver and lung. Moreover. the doss-response relationships for coumarin-induced toxicity and carcinogenicity are non-linear, with tumour formation only being observed at high doses which are associated with hepatic and pulmonary toxicity. Other species, including the Syrian hamster, are seemingly resistant to coumarin-induced toxicity. There are marked differences in coumarin metabolism between susceptible rodent species and other species including humans. It appears that the 7-hydroxylation pathway of coumarin metabolism, the major pathway in most human subjects but only a minor pathway in the rat and mouse, is a detoxification pathway. In contrast, the major route of coumarin metabolism in the rat and mouse is by a 3,4-epoxidation pathway resulting in the formation of toxic metabolites. The maximum daily human exposure to coumarin from dietary sources for a 60-kg consumer has been estimated to be 0.02 mg/kg/day. From fragrance use in cosmetic products, coumarin exposure has been estimated to be 0.04 mg/kg/day. The total daily human exposure From dietary sources together with fragrance use in cosmetic products is thus 0.06 mg/kg/day. No adverse effects of coumarin have been reported in susceptible species in response to doses which are more than 100 rimes the maximum human daily intake. The mechanism of coumarin-induced tumour formation in rodents is associated with metabolism-mediated, toxicity and it is concluded that exposure to coumarin From food and/or cosmetic products poses no health risk to humans. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:423 / 453
页数:31
相关论文
共 216 条
[31]   PHASE-II STUDY OF COUMARIN AND CIMETIDINE IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA [J].
DEXEUS, FH ;
LOGOTHETIS, CJ ;
SELLA, A ;
FITZ, K ;
AMATO, R ;
REUBEN, JM ;
DOZIER, N .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (02) :325-329
[32]   EXPRESSION AND ALTERNATIVE SPLICING OF THE CYTOCHROME-P-450 CYP2A7 [J].
DING, SH ;
LAKE, BG ;
FRIEDBERG, T ;
WOLF, CR .
BIOCHEMICAL JOURNAL, 1995, 306 :161-166
[33]   COMPARISON OF MONGOLIAN GERBIL AND RAT HEPATIC-MICROSOMAL MONOOXYGENASE ACTIVITIES - HIGH COUMARIN 7-HYDROXYLASE ACTIVITY IN THE GERBIL [J].
DOMINGUEZ, K ;
FENTEM, JH ;
GARLE, MJ ;
FRY, JR .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (10) :1629-1631
[34]  
Donato MT, 1998, ATLA-ALTERN LAB ANIM, V26, P213
[35]   Inhibition of coumarin 7-hydroxylase activity in human liver microsomes [J].
Draper, AJ ;
Madan, A ;
Parkinson, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 341 (01) :47-61
[36]   HUMAN LIVER-MICROSOMES ARE EFFICIENT CATALYSTS OF 1,3-BUTADIENE OXIDATION - EVIDENCE FOR MAJOR ROLES BY CYTOCHROMES P450 2A6 AND 2E1 [J].
DUESCHER, RJ ;
ELFARRA, AA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 311 (02) :342-349
[37]   Inhibition of the mutagenicity of 2-nitrofluorene, 3-nitrofluoranthene and 1-nitropyrene by flavonoids, coumarins, quinones and other phenolic compounds [J].
Edenharder, R ;
Tang, X .
FOOD AND CHEMICAL TOXICOLOGY, 1997, 35 (3-4) :357-372
[38]   CONTRIBUTION OF CYP1A1, AND CYP1A2 TO THE ACTIVATION OF HETEROCYCLIC AMINES IN MONKEYS AND HUMAN [J].
EDWARDS, RJ ;
MURRAY, BP ;
MURRAY, S ;
SCHULZ, T ;
NEUBERT, D ;
GANT, TW ;
THORGEIRSSON, SS ;
BOOBIS, AR ;
DAVIES, DS .
CARCINOGENESIS, 1994, 15 (05) :829-836
[39]   THE PHARMACOLOGY, METABOLISM, ANALYSIS, AND APPLICATIONS OF COUMARIN AND COUMARIN-RELATED COMPOUNDS [J].
EGAN, D ;
OKENNEDY, R ;
MORAN, E ;
COX, D ;
PROSSER, E ;
THORNES, RD .
DRUG METABOLISM REVIEWS, 1990, 22 (05) :503-529
[40]   RAPID AND SENSITIVE DETERMINATION OF COUMARIN AND 7-HYDROXYCOUMARIN AND ITS GLUCURONIDE CONJUGATE IN URINE AND PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
EGAN, DA ;
OKENNEDY, R .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 582 (1-2) :137-143